DK1753732T3 - Phenylsulfamater som aromataseinhibitorer - Google Patents

Phenylsulfamater som aromataseinhibitorer

Info

Publication number
DK1753732T3
DK1753732T3 DK05747149.2T DK05747149T DK1753732T3 DK 1753732 T3 DK1753732 T3 DK 1753732T3 DK 05747149 T DK05747149 T DK 05747149T DK 1753732 T3 DK1753732 T3 DK 1753732T3
Authority
DK
Denmark
Prior art keywords
phenylsulfamates
aromatase inhibitors
independently
hydrocarbyl
groups
Prior art date
Application number
DK05747149.2T
Other languages
English (en)
Inventor
Lok Wai Lawrence Woo
Toby Jackson
Christian Bubert
Atul Purohit
Michael John Reed
Barry Victor Lloyd Potter
Original Assignee
Sterix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterix Ltd filed Critical Sterix Ltd
Application granted granted Critical
Publication of DK1753732T3 publication Critical patent/DK1753732T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
DK05747149.2T 2004-06-04 2005-06-03 Phenylsulfamater som aromataseinhibitorer DK1753732T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0412492.1A GB0412492D0 (en) 2004-06-04 2004-06-04 Compound
PCT/GB2005/002194 WO2005118560A1 (en) 2004-06-04 2005-06-03 Phenyl-sulfamates as aromatase inhibitors

Publications (1)

Publication Number Publication Date
DK1753732T3 true DK1753732T3 (da) 2010-04-12

Family

ID=32696670

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05747149.2T DK1753732T3 (da) 2004-06-04 2005-06-03 Phenylsulfamater som aromataseinhibitorer

Country Status (9)

Country Link
US (2) US7763642B2 (da)
EP (1) EP1753732B1 (da)
AT (1) ATE450516T1 (da)
DE (1) DE602005018049D1 (da)
DK (1) DK1753732T3 (da)
ES (1) ES2337804T3 (da)
GB (1) GB0412492D0 (da)
PL (1) PL1753732T3 (da)
WO (1) WO2005118560A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1751121A2 (en) * 2005-04-06 2007-02-14 Sicor Inc. Process for the preparation of anastrozole
GB0525323D0 (en) * 2005-12-13 2006-01-18 Sterix Ltd Compound
US8093279B2 (en) 2005-12-13 2012-01-10 Gillian Reed, legal representative Compound
US20100204146A1 (en) 2007-09-17 2010-08-12 Preglem S.A. Treatment of Oestrogen Dependant Conditions in Pre-menopausal Women
WO2015100609A1 (en) * 2013-12-31 2015-07-09 Beaufour Ipsen Tianjin Pharmaceutical Co., Ltd New substituted biphenyl analogues as dual inhibitors of aromatase and sulfatase
KR20180038460A (ko) * 2015-07-21 2018-04-16 이뮤노젠 아이엔씨 세포독성 벤조다이아제핀 유도체의 제조 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714013D0 (en) 1987-06-16 1987-07-22 Ici Plc (substituted-aralkyl)heterocyclic compounds
GB9003939D0 (en) 1990-02-21 1990-04-18 Imperial College Sulphatase inhibitors
GB9118478D0 (en) 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
GB9118465D0 (en) 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
GB9422777D0 (en) 1994-11-11 1995-01-04 Imperial College Assay
US5723315A (en) 1996-08-23 1998-03-03 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
CA2263154A1 (en) 1996-08-07 1998-02-12 Darwin Discovery Limited Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
DE69637856D1 (en) 1996-08-30 2009-04-16 Human Genome Sciences Inc Interleukin-19.
US6126939A (en) 1996-09-03 2000-10-03 Yeda Research And Development Co. Ltd. Anti-inflammatory dipeptide and pharmaceutical composition thereof
ES2217428T3 (es) 1996-09-25 2004-11-01 Ss Pharmaceutical Co., Ltd. Derivados de vinilpiridina sustituidos y medicamentos que los contienen.
CA2324424A1 (en) 1998-03-26 1999-10-07 Kyowa Hakko Kogyo Co., Ltd. Method for searching steroid sulfatase inhibitors
GB9807779D0 (en) 1998-04-09 1998-06-10 Ciba Geigy Ag Organic compounds
MXPA02004443A (es) * 1999-11-04 2002-09-02 Basilea Pharmaceutica Ag 5-bencil-2,4-diaminopirimidinas sustituidas.
US20030220386A1 (en) * 2000-09-22 2003-11-27 Andrew Plant Delta 1-pyrrolines for use as pesticides
CA2464770C (en) * 2001-11-21 2011-08-16 Sterix Limited Compound
GB0525323D0 (en) * 2005-12-13 2006-01-18 Sterix Ltd Compound

Also Published As

Publication number Publication date
GB0412492D0 (en) 2004-07-07
PL1753732T3 (pl) 2010-05-31
US20110021586A1 (en) 2011-01-27
ATE450516T1 (de) 2009-12-15
WO2005118560A1 (en) 2005-12-15
EP1753732A1 (en) 2007-02-21
EP1753732B1 (en) 2009-12-02
US20070117855A1 (en) 2007-05-24
US8470860B2 (en) 2013-06-25
DE602005018049D1 (en) 2010-01-14
US7763642B2 (en) 2010-07-27
ES2337804T3 (es) 2010-04-29

Similar Documents

Publication Publication Date Title
ECSP20027480A (es) Indolil alquil amino derivados sustituidos como nuevos inhibidores de la histona desacetilasa
ATE338461T1 (de) Pyrazolpyrimidinfungizide
ATE389635T1 (de) Pharmazeutisch wirksame piperidinderivate
CO6160235A2 (es) Isoxazolinas insecticidas
DK1981874T3 (da) Aminophenylderivater som nye inhibitorer af histondeacetylase
DK1899325T3 (da) Imidazolinon- og hydantoinderivater som hidtil ukendte hæmmere af histondeacetylase
DK1981871T3 (da) Heterocyclylalkylderivater som hidtil ukendte inhibitorer af histondeacetylase
ATE546467T1 (de) Ortho-nitrosophenole als polymerisationshemmer
CY1114213T1 (el) Μεθοδοι απομονωσης κρυσταλλικης μορφης ι της 5-αζακυτιδινης
ECSP10010272A (es) Derivados bis-(sulfonilamino) para uso en terapia
BRPI0506843A (pt) composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto
UY30499A1 (es) Derivados de amina utiles como agentes anticancerigenos
NO20061317L (no) Imidazopyridinderivater som induserbare NO-syntaseinhibatorer
DK1480644T3 (da) Heterocykliske forbindelser, der er aktive som inhibitorer af beta-lactamaser
DK1753732T3 (da) Phenylsulfamater som aromataseinhibitorer
ATE411030T1 (de) Phosphonatanaloga von hiv- integrasehemmerverbindungen
RS51226B (sr) Derivati azapeptida kao inhibitori hiv proteaze
DK1943232T3 (da) Kvadratsyrederivater som inhibitorer af histondeacetylase
RS53523B1 (en) ANILINE-PYRIMIDINE DERIVATIVES WITH SUBSTITUTED SULFOXIMIN AS CDK INHIBITORS, THEIR PRODUCTION AND USE AS MEDICINES
DE502006008710D1 (de) Substituierte tetrahydroisochinoline als mmp-inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament
NO20061344L (no) Imidazopyridinderivater som induserbare NO-syntaseoinhibitorer
NO20061316L (no) Imidazopyndinderivater som induserbare NO-syntaseinhibitorer
ATE469647T1 (de) Thienoä3,2-cüpyridin-7-carbonsäure-derivate
ATE421505T1 (de) 4-aminobenzofuranverbindungen als phosphodiesterase-4-inhibitoren
DE602004014523D1 (de) Imidazoä4,5-büpyridinderivate als inhibitoren der induzierbaren no-synthase